Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.36 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.35 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.35 |
| ▸ | F10 | P00742 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18650898 | 0.89 | USP30 (0.45) | PKMUSP2 | |
| SCHEMBL18667872 | 0.83 | PIK3CA (0.39) | PKMUSP2LRRK2PTGS2KLKB1 | |
| SCHEMBL18650911 | 0.83 | PIK3CA (0.39) | PKMUSP2LRRK2PTGS2KLKB1 | |
| SCHEMBL23618026 | 0.82 | PTGS2 (0.41) | LRRK2PTGS2RPS6KB1KLKB1F10 | |
| SCHEMBL18650901 | 0.82 | PTGS2 (0.46) | PTGS2RPS6KB1F10 | |
| SCHEMBL18668039 | 0.80 | PTGS2 (0.40) | LRRK2PTGS2F10 | |
| SCHEMBL23617944 | 0.80 | PTGS2 (0.41) | LRRK2PTGS2RPS6KB1F10 | |
| SCHEMBL18650909 | 0.79 | PTGS2 (0.40) | PTGS2RPS6KB1F10 | |
| SCHEMBL18668092 | 0.78 | PTGS2 (0.40) | LRRK2PTGS2RPS6KB1F10 | |
| SCHEMBL18650891 | 0.78 | GPR119 (0.37) | LRRK2PTGS2RPS6KB1F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3350177-B1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2021-07-07 | — | — | EP | disclosed |